An independent, third-party organization may develop and implement the cancer clinical trial participation program to provide reimbursement to subjects for ancillary costs associated with participation in a cancer clinical trial, including costs for:
(1) travel;
(2) lodging;
(3) parking and tolls; and
(4) other costs considered appropriate by the organization.